Skip to main content
Journal cover image

Initial Clinical Outcome With Bilateral, Dual-Target Deep Brain Stimulation Trial in Parkinson Disease Using Summit RC + S.

Publication ,  Journal Article
Mitchell, KT; Schmidt, SL; Cooney, JW; Grill, WM; Peters, J; Rahimpour, S; Lee, H-J; Jung, S-H; Mantri, S; Scott, B; Lad, SP; Turner, DA
Published in: Neurosurgery
July 1, 2022

BACKGROUND: Deep brain stimulation (DBS) is an effective therapy in advanced Parkinson disease (PD). Although both subthalamic nucleus (STN) and globus pallidus (GP) DBS show equivalent efficacy in PD, combined stimulation may demonstrate synergism. OBJECTIVE: To evaluate the clinical benefit of stimulating a combination of STN and GP DBS leads and to demonstrate biomarker discovery for adaptive DBS therapy in an observational study. METHODS: We performed a pilot trial (n = 3) of implanting bilateral STN and GP DBS leads, connected to a bidirectional implantable pulse generator (Medtronic Summit RC + S; NCT03815656, IDE No. G180280). Initial 1-year outcome in 3 patients included Unified PD Rating Scale on and off medications, medication dosage, Hauser diary, and recorded beta frequency spectral power. RESULTS: Combined DBS improved PD symptom control, allowing >80% levodopa medication reduction. There was a greater decrease in off-medication motor Unified PD Rating Scale with multiple electrodes activated (mean difference from off stimulation off medications -18.2, range -25.5 to -12.5) than either STN (-12.8, range -20.5 to 0) or GP alone (-9, range -11.5 to -4.5). Combined DBS resulted in a greater reduction of beta oscillations in STN in 5/6 hemispheres than either site alone. Adverse events occurred in 2 patients, including a small cortical hemorrhage and seizure at 24 hours postoperatively, which resolved spontaneously, and extension wire scarring requiring revision at 2 months postoperatively. CONCLUSION: Patients with PD preferred combined DBS stimulation in this preliminary cohort. Future studies will address efficacy of adaptive DBS as we further define biomarkers and control policy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neurosurgery

DOI

EISSN

1524-4040

Publication Date

July 1, 2022

Volume

91

Issue

1

Start / End Page

132 / 138

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Subthalamic Nucleus
  • Parkinson Disease
  • Neurology & Neurosurgery
  • Humans
  • Globus Pallidus
  • Deep Brain Stimulation
  • 5202 Biological psychology
  • 3209 Neurosciences
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mitchell, K. T., Schmidt, S. L., Cooney, J. W., Grill, W. M., Peters, J., Rahimpour, S., … Turner, D. A. (2022). Initial Clinical Outcome With Bilateral, Dual-Target Deep Brain Stimulation Trial in Parkinson Disease Using Summit RC + S. Neurosurgery, 91(1), 132–138. https://doi.org/10.1227/neu.0000000000001957
Mitchell, Kyle T., Stephen L. Schmidt, Jeffrey W. Cooney, Warren M. Grill, Jennifer Peters, Shervin Rahimpour, Hui-Jie Lee, et al. “Initial Clinical Outcome With Bilateral, Dual-Target Deep Brain Stimulation Trial in Parkinson Disease Using Summit RC + S.Neurosurgery 91, no. 1 (July 1, 2022): 132–38. https://doi.org/10.1227/neu.0000000000001957.
Mitchell KT, Schmidt SL, Cooney JW, Grill WM, Peters J, Rahimpour S, et al. Initial Clinical Outcome With Bilateral, Dual-Target Deep Brain Stimulation Trial in Parkinson Disease Using Summit RC + S. Neurosurgery. 2022 Jul 1;91(1):132–8.
Mitchell, Kyle T., et al. “Initial Clinical Outcome With Bilateral, Dual-Target Deep Brain Stimulation Trial in Parkinson Disease Using Summit RC + S.Neurosurgery, vol. 91, no. 1, July 2022, pp. 132–38. Pubmed, doi:10.1227/neu.0000000000001957.
Mitchell KT, Schmidt SL, Cooney JW, Grill WM, Peters J, Rahimpour S, Lee H-J, Jung S-H, Mantri S, Scott B, Lad SP, Turner DA. Initial Clinical Outcome With Bilateral, Dual-Target Deep Brain Stimulation Trial in Parkinson Disease Using Summit RC + S. Neurosurgery. 2022 Jul 1;91(1):132–138.
Journal cover image

Published In

Neurosurgery

DOI

EISSN

1524-4040

Publication Date

July 1, 2022

Volume

91

Issue

1

Start / End Page

132 / 138

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Subthalamic Nucleus
  • Parkinson Disease
  • Neurology & Neurosurgery
  • Humans
  • Globus Pallidus
  • Deep Brain Stimulation
  • 5202 Biological psychology
  • 3209 Neurosciences
  • 3202 Clinical sciences